Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole (D961H) for RE Maintenance and GU/DU Prevention in Japanese Children
NCT03553563Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2018
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in reflux esophagitis, gastric ulcer, duodenal ulcer, sponsored by AstraZeneca. Started Jul 2018; status: completed.
02
Drugs
esomeprazole
03
Conditions
reflux esophagitisgastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT03553563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553563.